Consistent MYORG Downregulation in DMD and LGMD: Transcriptomic and Proteomic Evidence Supporting Deoxygalactonojirimycin Repurposing
Rangaprasad Sarangarajan, Kastoori Iyengar
The paper identifies consistent MYORG downregulation in DMD and LGMD through transcriptomic and proteomic analysis, supporting the repurposing of deoxygalactonojirimycin as a pharmacological chaperone.
bioRxiv · Aug 29, 2026 · PreprintGenomics